These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15158079)

  • 1. Transient dopamine synthesis modulation in prefrontal cortex: in vitro studies.
    Dumont NL; Andersen SL; Thompson AP; Teicher MH
    Brain Res Dev Brain Res; 2004 Jun; 150(2):163-6. PubMed ID: 15158079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization.
    Sorg BA; Li N; Wu WR
    J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
    Papadeas ST; Blake BL; Knapp DJ; Breese GR
    J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.
    Grobin AC; Deutch AY
    J Pharmacol Exp Ther; 1998 Apr; 285(1):350-7. PubMed ID: 9536031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?
    Cools AR; Lubbers L; van Oosten RV; Andringa G
    Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
    Laplante F; Srivastava LK; Quirion R
    J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS; Mabrouk OS; Pehek EA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.
    Mannoury la Cour C; Vidal S; Pasteau V; Cussac D; Millan MJ
    Neuropharmacology; 2007 Mar; 52(3):1003-14. PubMed ID: 17178132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization.
    Goto Y; Grace AA
    Neuron; 2005 Jul; 47(2):255-66. PubMed ID: 16039567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of (-)-stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats.
    Guo X; Liu J; Zou LL; Jin J; Wang BC; Jin GZ
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):100-3. PubMed ID: 10374628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats.
    de Jong IE; van den Buuse M
    Neuropharmacology; 2006 Sep; 51(3):438-46. PubMed ID: 16740279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.